Although control IgG did not affect the Dox plus IL-12–mediated inhibition of tumor growth, the NKG2D-blocking antibody completely reversed Dox plus IL-12–mediated inhibition of tumor growth (Figure 6A). The gene discussed is KLRK1; the disease is neoplasm.